CNTB
NASDAQ · Biotechnology
Connect Biopharma Holdings L
$2.38
+0.00 (+0.00%)
Open$2.40
Previous Close$2.38
Day High$2.48
Day Low$2.37
52W High$3.82
52W Low$0.91
Volume—
Avg Volume370.3K
Market Cap137.89M
P/E Ratio—
EPS$-1.15
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+763.9% upside
Current
$2.38
$2.38
Target
$20.56
$20.56
$15.18
$20.56 avg
$23.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 68.6K | 69.44M | 70.73M |
| Net Income | -62,194,375 | 4.31M | 5.04M |
| Profit Margin | -86,687.5% | 6.2% | 7.1% |
| EBITDA | -64,309,533 | 5.85M | 6.49M |
| Free Cash Flow | — | 3.99M | 3.58M |
| Rev Growth | — | +2.8% | -4.7% |
| Debt/Equity | — | 0.90 | 0.87 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |